These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29147262)

  • 1. Accuracy of Cytology Specimen and Needle Core Biopsies for Detection of
    Swati I; Zhang S; Tull J; Khurana KK
    World J Oncol; 2011 Dec; 2(6):275-280. PubMed ID: 29147262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.
    Treece AL; Montgomery ND; Patel NM; Civalier CJ; Dodd LG; Gulley ML; Booker JK; Weck KE
    Cancer Cytopathol; 2016 Jun; 124(6):406-14. PubMed ID: 26882436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations.
    Noll B; Wang WL; Gong Y; Zhao J; Kalhor N; Prieto V; Staerkel G; Roy-Chowdhuri S
    Cancer Cytopathol; 2018 May; 126(5):342-352. PubMed ID: 29499101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer.
    Lee SE; Lee SY; Park HK; Oh SY; Kim HJ; Lee KY; Kim WS
    J Korean Med Sci; 2016 Aug; 31(8):1224-30. PubMed ID: 27478332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer.
    Bozzetti C; Naldi N; Nizzoli R; Azzoni C; Bortesi B; Zobbi V; Bottarelli L; Tiseo M; Gasparro D; Majori M; De Filippo M; Ardizzoni A
    Lung Cancer; 2013 Apr; 80(1):35-8. PubMed ID: 23352033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas.
    Khode R; Larsen DA; Culbreath BC; Parrish S; Walker KL; Sayage-Rabie L; Beissner RS; Rao A
    Cancer Cytopathol; 2013 Jul; 121(7):361-9. PubMed ID: 23364874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR, KRAS, BRAF and HER2 testing in metastatic lung adenocarcinoma: Value of testing on samples with poor specimen adequacy and analysis of discrepancies.
    Forest F; Stachowicz ML; Casteillo F; Karpathiou G; Gouzy-Grosjean F; Guilaubey C; Cottier M; Beal J; Clemenson A; Péoc'h M
    Exp Mol Pathol; 2017 Dec; 103(3):306-310. PubMed ID: 29175303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens.
    Billah S; Stewart J; Staerkel G; Chen S; Gong Y; Guo M
    Cancer Cytopathol; 2011 Apr; 119(2):111-7. PubMed ID: 21400670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of EGFR and KRAS mutation status from FNAs and core-needle biopsies of non-small cell lung cancer.
    Lozano MD; Labiano T; Echeveste J; Gurpide A; Martín-Algarra S; Zhang G; Sharma A; Palma JF
    Cancer Cytopathol; 2015 Apr; 123(4):230-6. PubMed ID: 25529460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR analysis on scrapings from cytology smears in lung carcinoma, an effective alternative to testing on trucut biopsies.
    Mohan AA; Vallonthaiel AG; Nambiar A; Ariyannur P; Joy RA; Thelakkattusserry SK; Vikkath N; Joseph T; Mehta A; Perathur A
    Diagn Cytopathol; 2021 Oct; 49(10):1155-1163. PubMed ID: 34432954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma.
    Pang NK; Nga ME; Chin SY; Ismail TM; Lim GL; Soong R; Salto-Tellez M
    Cytopathology; 2011 Dec; 22(6):358-64. PubMed ID: 21029218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of EGFR and KRAS mutations in fine-needle aspirates stored on Whatman FTA cards: is this the tool for biobanking cytological samples in the molecular era?
    da Cunha Santos G; Liu N; Tsao MS; Kamel-Reid S; Chin K; Geddie WR
    Cancer Cytopathol; 2010 Dec; 118(6):450-6. PubMed ID: 21240995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of EGFR mutation in pathologically non-malignant specimens from computed tomography-guided lung needle biopsies.
    Ueno T; Soh J; Hiraki T; Asano H; Ichimura K; Shibamoto K; Gobara H; Kanazawa S; Toyooka S; Miyoshi S
    Oncol Lett; 2012 Feb; 3(2):401-404. PubMed ID: 22740920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core needle lung biopsy specimens: adequacy for EGFR and KRAS mutational analysis.
    Solomon SB; Zakowski MF; Pao W; Thornton RH; Ladanyi M; Kris MG; Rusch VW; Rizvi NA
    AJR Am J Roentgenol; 2010 Jan; 194(1):266-9. PubMed ID: 20028932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR mutation testing using archival-stained smears in non-small cell lung carcinoma.
    Ozluk Y; Firat P; Yegen G; Hocaoglu J; Tas S; Yilmazbayhan D
    Cytopathology; 2017 Feb; 28(1):35-45. PubMed ID: 27389045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of EGFR mutation status in cytology specimens: an institutional experience.
    Aisner DL; Deshpande C; Baloch Z; Watt CD; Litzky LA; Malhotra B; Sepulveda AR; Langer C; Evans T; Van Deerlin VM
    Diagn Cytopathol; 2013 Apr; 41(4):316-23. PubMed ID: 22102479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Idylla KRAS assay on extracted DNA and de-stained cytology smears: Can we rescue small sample?
    Wei Q; Eltoum IA; Mackinnon AC; Harada S
    Ann Diagn Pathol; 2022 Oct; 60():152023. PubMed ID: 35961282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS mutational status of endoscopic biopsies matches resection specimens.
    Yang QH; Schmidt J; Soucy G; Odze R; Dejesa-Jamanila L; Arnold K; Kuslich C; Lash R
    J Clin Pathol; 2012 Jul; 65(7):604-7. PubMed ID: 22461648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of core roll preparations in immediate assessment of neoplastic lung lesions: comparison to conventional CT scan-guided lung fine-needle aspiration cytology.
    Chandan VS; Zimmerman K; Baker P; Scalzetti E; Khurana KK
    Chest; 2004 Sep; 126(3):739-43. PubMed ID: 15364750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.
    Liu Y; Wu BQ; Zhong HH; Hui P; Fang WG
    Int J Clin Exp Pathol; 2013; 6(9):1880-9. PubMed ID: 24040454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.